Clinical TrialsSearch results
Number of results: 316
Not yet recruiting
- A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants with Relapsed or Refractory Myeloma who Have Received an Anti-CD38 Antibody and Lenalidomide
- Relapsed or Refractory Multiple Myeloma
- Nishikawa Kazuko
- 2024-04-12
Recruiting
- Basic research on physiological and biochemical reactions during the use of BS fine clothing and bedding
- Not targeting any disease.
- Tainaka Kazuki
- 2024-03-14
Recruiting
- Feasibility study of a smartphone application in type 2 diabetes with stage 2 diabetic nephropathy
- Type 2 diabetes mellitus with stage 2 diabetic nephropathy
- Hirohito Sone
- 2024-03-05
Recruiting
- A Multicentre, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy, Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants With Cirrhosis
- cirrhosis
- Ageishi Yuji
- 2024-02-29
Not yet recruiting
- jDAPA-PD
- Chronic heart failure, chronic kidney disease
- Yamamoto Suguru
- 2024-02-08
Recruiting
- Renal Anemia Treatment with Roxadustat for Non-dialysis Patients with Lower Extremity Artery Disease: The REFINE trial
- lower extremities artery disease, renal anemia
- Ueki Yasushi
- 2023-12-12
Recruiting
- Exploratory Study on Establishing Optimal Stimulation Conditions through Transcutaneous Vagus Nerve Stimulation of the Auricular Concha
- Not targeting any disease.
- Tainaka Kazuki
- 2023-11-09
Recruiting
- A study of silorimus for pure red cell aplasia
- acquired chronic pure red cell aplasia
- Nakazawa Hideyuki
- 2023-08-28
Recruiting
- Functional cerebral small vessel studies for HTRA1-related cerebral small vessel disease
- CARASIL, HTRA1-related cerebral small vessel disease
- Onodera Osamu
- 2023-07-14
Other
- A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
- Dominantly Inherited Alzheimer's Disease
- Bateman J. Randall
- 2023-06-07